BGM Stock Overview
Manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BGM Group Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.50 |
| 52 Week High | US$11.67 |
| 52 Week Low | US$1.78 |
| Beta | 1.54 |
| 1 Month Change | 21.43% |
| 3 Month Change | 7.59% |
| 1 Year Change | 277.95% |
| 3 Year Change | -40.35% |
| 5 Year Change | n/a |
| Change since IPO | -83.00% |
Recent News & Updates
Qilian International Holding Group Limited (NASDAQ:BGM) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Sep 17
Qilian International Holding Group Limited's (NASDAQ:QLI) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Jun 22The Market Doesn't Like What It Sees From Qilian International Holding Group Limited's (NASDAQ:QLI) Revenues Yet
May 02Recent updates
Qilian International Holding Group Limited (NASDAQ:BGM) Surges 29% Yet Its Low P/S Is No Reason For Excitement
Sep 17Qilian International Holding Group Limited's (NASDAQ:QLI) Share Price Boosted 34% But Its Business Prospects Need A Lift Too
Jun 22The Market Doesn't Like What It Sees From Qilian International Holding Group Limited's (NASDAQ:QLI) Revenues Yet
May 02Earnings Not Telling The Story For Qilian International Holding Group Limited (NASDAQ:QLI) After Shares Rise 79%
Dec 31Qilian International Non-GAAP EPS of $0.01, revenue of $32.09M
Oct 03We Think You Can Look Beyond Qilian International Holding Group's (NASDAQ:QLI) Lackluster Earnings
Sep 23Qilian International signs Gan Di Xin's exclusive distribution agreement
May 05Qilian International Holding Group Limited's (NASDAQ:QLI) Share Price Matching Investor Opinion
Apr 12Shareholder Returns
| BGM | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -1.2% | -2.0% | -3.5% |
| 1Y | 277.9% | 7.6% | 22.1% |
Return vs Industry: BGM exceeded the US Pharmaceuticals industry which returned 7.6% over the past year.
Return vs Market: BGM exceeded the US Market which returned 22.1% over the past year.
Price Volatility
| BGM volatility | |
|---|---|
| BGM Average Weekly Movement | 11.4% |
| Pharmaceuticals Industry Average Movement | 10.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BGM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BGM's weekly volatility has decreased from 21% to 11% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 298 | Chen Xin | www.bgm.ltd |
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications.
BGM Group Ltd Fundamentals Summary
| BGM fundamental statistics | |
|---|---|
| Market cap | US$231.43m |
| Earnings (TTM) | -US$7.86m |
| Revenue (TTM) | US$29.87m |
7.7x
P/S Ratio-29.4x
P/E RatioIs BGM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BGM income statement (TTM) | |
|---|---|
| Revenue | US$29.87m |
| Cost of Revenue | US$29.00m |
| Gross Profit | US$870.77k |
| Other Expenses | US$8.73m |
| Earnings | -US$7.86m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.29 |
| Gross Margin | 2.92% |
| Net Profit Margin | -26.32% |
| Debt/Equity Ratio | 0% |
How did BGM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 01:48 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BGM Group Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|